Abstract
Hyperthyroidism-associated bone loss has been attributed to excess of thyroid hormones. Animal studies, however, suggest that TSH deficiency might affect bone turnover independently of thyroid hormones. Here, I discuss the study by Heemstra and colleagues, who assessed the relationship between serum TSH level and markers of bone turnover in patients with thyroid cancer receiving supraphysiological doses of levothyroxine. The effect of thyroid hormones could not be distinguished from that of TSH as the intact hypothalamic–pituitary–thyroid axis maintained the typical inverse relationship between thyroid hormones and TSH. The study included 27 men and 76 premenopausal women, although previous data indicate that suppressive doses of levothyroxine have no effect on BMD in such patients. Accordingly, Heemstra et al. did not identify a relationship between TSH level and BMD. Although mechanisms of thyrotoxicosis-related bone loss remain controversial, postmenopausal women with thyroid cancer who require long-term TSH suppression should be monitored carefully for osteoporosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Murphy E and Williams GR (2004) The thyroid and the skeleton. Clin Endocrinol 61: 285–298
Bassett JHD and Williams GR (2008) Critical role of the hypothalamic-pituitary-thyroid axis in bone. Bone 43: 418–426
Heemstra KA et al. (2008) Thyroid hormone independent associations between serum TSH levels and indicators of bone turnover in cured patients with differentiated thyroid carcinoma. Eur J Endocrinol 159: 69–76
Biondi B et al. (2005) Thyroid-hormone therapy and thyroid cancer: a reassessment. Nat Clin Pract Endocrinol Metab 1: 32–40
van der Deure WM et al. (2008) Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam Study. Clin Endocrinol 68: 175–181
Mazziotti G et al. (2005) Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. J Bone Miner Res 20: 480–486
Giusti M et al. (2007) Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinoma. Hormones 6: 304–313
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Williams, G. Does serum TSH level have thyroid hormone independent effects on bone turnover?. Nat Rev Endocrinol 5, 10–11 (2009). https://doi.org/10.1038/ncpendmet1004
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet1004
This article is cited by
-
Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies
Osteoporosis International (2016)